DZ Bank
NBIX icon

DZ Bank’s Neurocrine Biosciences NBIX Stock Holding History

DZ Bank’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Buy
112,059
+4,263
+4% +$632K 0.01% 294
2026
Q1 		$14.2M Buy
107,796
+107,128
+16,037% +$14.2M 0.01% 333
2025
Q4 		$94.7K Buy
+668
New +$96.8K ﹤0.01% 925
2024
Q3 		– Sell
-12,122
Closed -$1.67M – 1036
2024
Q2 		$1.67M Sell
12,122
-16,344
-57% -$2.24M ﹤0.01% 605
2024
Q1 		$3.93M Buy
28,466
+9,955
+54% +$1.36M ﹤0.01% 502
2023
Q4 		$2.44M Sell
18,511
-1,969
-10% -$227K ﹤0.01% 548
2023
Q3 		$2.3M Sell
20,480
-19,821
-49% -$2.09M ﹤0.01% 545
2023
Q2 		$3.8M Sell
40,301
-9,575
-19% -$936K 0.01% 499
2023
Q1 		$5.05M Sell
49,876
-2,271
-4% -$236K 0.01% 454
2022
Q4 		$6.23M Buy
52,147
+16,943
+48% +$1.98M 0.01% 419
2022
Q3 		$3.74M Buy
35,204
+23,516
+201% +$2.39M 0.01% 477
2022
Q2 		$1.14M Hold
11,688
– – ﹤0.01% 697
2022
Q1 		$1.1M Sell
11,688
-22,326
-66% -$1.89M ﹤0.01% 720
2021
Q4 		$2.89M Buy
34,014
+29,311
+623% +$2.7M ﹤0.01% 680
2021
Q3 		$451K Buy
+4,703
New +$444K ﹤0.01% 786
2018
Q2 		– Sell
-60,700
Closed -$5.03M – 1010
2018
Q1 		$5.03M Buy
+60,700
New +$5.13M 0.02% 399

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

DZ Bank's NBIX Position: Q2 2026 in Review

DZ Bank increased its Neurocrine Biosciences (NBIX) stake by 4% in Q2 2026, buying an estimated $632K and bringing the position to 112,059 shares worth $18.9M. The position accounts for 0.01% of the portfolio, ranked #294.

DZ Bank first reported a position in NBIX in Q1 2018 and has held it in 16 quarters since. 775 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • DZ Bank held 112,059 shares of Neurocrine Biosciences worth $18.9M as of Q2 2026.
  • DZ Bank bought 4,263 Neurocrine Biosciences shares in Q2 2026, an estimated $632K.
  • Neurocrine Biosciences made up 0.01% of DZ Bank's portfolio in Q2 2026, its #294 holding.
  • DZ Bank first reported a position in Neurocrine Biosciences in Q1 2018 and has held it in 16 quarters since.
  • 775 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.